<DOC>
	<DOCNO>NCT01718886</DOCNO>
	<brief_summary>The objective study evaluate initial safety preliminary effectiveness Obalon intragastric balloon system European subject BMI range 27 - 35 kg/m^2</brief_summary>
	<brief_title>European Study Evaluate Preliminary Safety Efficacy Multiple Obalon Gastric Balloons 12 Weeks Aid Weight Loss</brief_title>
	<detailed_description />
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<criteria>Were 2164 year age ; Had BMI 2735 Kg/cm Did history weight reduction 5 % body weight past 6 month Were able comply study requirement duration study outline protocol . This include comply visit schedule well study specific procedure : electrocardiography , endoscopy , upper gastrointestinal radiography clinical lab test Were able understand willing provide write informed consent Experienced difficulty swallowing ; Had unstable angina , myocardial infarction within past year , heart disease classify within New York Heart Association 's Class III IV functional capacity ; Taking chronic aspirin non steroidal antiinflammatory agent , medication know gastric irritant , willingness discontinue use concomitant medication , antiarrythmics , antianginal medication , anticoagulant medication congestive heart failure ; Taking blood pressure medication , unless blood pressure control stable dose least 3 month ; Had type 1 diabetes Type 2 diabetes require oral medication insulin ; Had history symptom thyroid disease control medication ; Had severe renal , hepatic , pulmonary disease cancer ; Had past history gastrointestinal surgery ( exclude uncomplicated appendectomy ) ; Had abnormal stenosis obstruction GI tract ; Had history adhesive peritonitis ; Had previously diagnose hiatal hernia great 2cm ; Had abnormality esophagus , stomach pylorus ; Had history severe esophagitis ; Had history symptom esophageal and/or gastric varix ; Had history congenital acquire GI anomaly ( e.g . atresia , stricture , /or diverticulum ) ; Had history symptom inflammatory bowel disease , Chron 's disease ; Had history of/ sign /or symptom duodenal gastric ulcer ; Untreated H.Pylori Had history sign dysphasia , achalasia symptom GI motility ; Were undergo chronic steroid immunosuppressive therapy ; Were pregnant breastfeeding intention become pregnant study ; Had placement previous intragastric balloon similar device ; Were use pharmaceutical agent weight loss ; Were drink alcohol excess use illicit drug ; Had bulimia binge eat disorder ; Had impend gastric surgery 30 day post balloon removal ; Had plan fly scuba dive activity balloon residence time ; Had condition , opinion investigator , would interfere participation compliance study ( i.e . psychosocial issue ) ; Were participate investigational study protocol . If subject recently complete participation another drug device study , subject must complete study least 30 day prior enrol study ; Had history know allergy component device material , include limited allergy porcine protein .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Weight loss</keyword>
	<keyword>Weight control</keyword>
	<keyword>Intragastric balloon</keyword>
	<keyword>gastric balloon</keyword>
</DOC>